Actinium Pharmaceuticals Inc (ATNM)
7.70
+0.32
(+4.34%)
USD |
NYAM |
Apr 30, 16:00
7.84
+0.14
(+1.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Max Drawdown (5Y): 97.29% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.29% |
| March 31, 2024 | 97.29% |
| February 29, 2024 | 97.29% |
| January 31, 2024 | 97.29% |
| December 31, 2023 | 97.29% |
| November 30, 2023 | 97.29% |
| October 31, 2023 | 97.29% |
| September 30, 2023 | 97.29% |
| August 31, 2023 | 97.29% |
| July 31, 2023 | 97.29% |
| June 30, 2023 | 97.29% |
| May 31, 2023 | 97.29% |
| April 30, 2023 | 97.29% |
| March 31, 2023 | 97.29% |
| February 28, 2023 | 97.38% |
| January 31, 2023 | 97.41% |
| December 31, 2022 | 97.41% |
| November 30, 2022 | 97.41% |
| October 31, 2022 | 97.41% |
| September 30, 2022 | 97.41% |
| August 31, 2022 | 97.41% |
| July 31, 2022 | 97.41% |
| June 30, 2022 | 97.41% |
| May 31, 2022 | 97.41% |
| April 30, 2022 | 97.41% |
| Date | Value |
|---|---|
| March 31, 2022 | 97.41% |
| February 28, 2022 | 97.41% |
| January 31, 2022 | 97.41% |
| December 31, 2021 | 97.41% |
| November 30, 2021 | 97.41% |
| October 31, 2021 | 97.41% |
| September 30, 2021 | 97.41% |
| August 31, 2021 | 97.41% |
| July 31, 2021 | 97.41% |
| June 30, 2021 | 97.41% |
| May 31, 2021 | 97.41% |
| April 30, 2021 | 97.41% |
| March 31, 2021 | 97.41% |
| February 28, 2021 | 97.41% |
| January 31, 2021 | 97.41% |
| December 31, 2020 | 97.41% |
| November 30, 2020 | 97.41% |
| October 31, 2020 | 97.41% |
| September 30, 2020 | 97.41% |
| August 31, 2020 | 97.41% |
| July 31, 2020 | 97.41% |
| June 30, 2020 | 97.41% |
| May 31, 2020 | 97.41% |
| April 30, 2020 | 97.41% |
| March 31, 2020 | 97.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.29%
Minimum
Mar 2023
97.41%
Maximum
May 2019
97.38%
Average
97.41%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics Inc | 91.70% |
| Eli Lilly and Co | 22.48% |
| Cellectar Biosciences Inc | 99.70% |
| Outlook Therapeutics Inc | 98.82% |
| Bristol-Myers Squibb Co | 42.61% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.371 |
| Beta (5Y) | 0.0835 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.43% |
| Historical Sharpe Ratio (5Y) | -0.066 |
| Historical Sortino (5Y) | -0.1743 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.48% |